CEBPB and metastatic malignant neoplasm: During the switch to metastatic cancer, tumor cells evade growth inhibitory functions of TGFβ by upregulating LIP, causing a block in C/EBPβ-induced p15INK4b activation and relieving c-Myc repression (48).